Stem Cells
Stem cell therapy is an emerging field in regenerative medicine. Current advancement in stem cell technology enables the growth and manipulation of the cells into a specialized function with characteristics that are on par with cells of various tissues, including nerve cells. This promising technology can help treat a wide range of human diseases, thus potentially reducing pain and embettering the lifestyle of people currently suffering from chronic or terminal conditions. This is possible due to two important characteristics that distinguish them from other cell types; that they are non-specialized, non-differentiated cells that are capable of renewing themselves through cell division, and that they can be manipulated to become tissue specific cells.
Pharmaseed Bioservices seeks to harness the recent advancements in stem cell technology, which has the capacity to affect considerably the current treatment provided to a broad array of intractable human diseases, including chronic CNS diseases, such as Alzheimer's disease and Parkinson's disease.
PharmaSeed's services include proof of concept of stem cell technology in animal models, and a battery of complementary services for the testing of stem cells effectiveness on oncology and neurodegenerative diseases.
Stem Cell Experimental Preclinical Models
Angiogenesis
- Hind-limb ischemia
- Corneal pocket models
- Cardiovascular model
Inflammation
- Osteoarthritis model
- Multiple sclerosis model
Neuropathic pain
- Spinal nerve injury (Chung model)
CNS
Please download PharmaSeed's Stem Cells brochure for additional information.
|
